Press Resease

Genomics Market - Global Industry Analysis

Genomics Market by Deliverables (Services and Products), by Application (Epigenomics, Functional, Biomarker Discovery, Pathway Analysis, and Others), and by End-User (Government and Academic Institutes, Clinical Research, Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 09-Apr-2019 Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-1080 Status : Published

Global genomics market expected to generate around USD 41.2 billion by 2025, at a CAGR of 14.2% between 2019 and 2025. The global genomics market has been split into deliverables, application, and end user. Based on deliverables, the genomics market includes services and products.

Description

The report covers a forecast and an analysis of the genomics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the bioinformatics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the genomics market on a global and regional level.

In order to give the users of this report a comprehensive view of the genomics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Genomics Market

The report provides company market share analysis to give a broader overview of the key players in the genomics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the genomics market on a global and regional basis.

The study provides a decisive view of the genomics market based on deliverables, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global genomics market are Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Eurofins Scientific, Agilent Technologies, Inc., GE Healthcare, BGI, Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, and F. Hoffmann-La Roche Ltd.

This report segments the global genomics market as follows:

Global Genomics Market: By Deliverables

  • Services
    • NGS-Based
    • Core Genomics
    • Computational
    • Biomarker Translation
    • Others
  • Products
    • Reagents
    • Instruments

Global Genomics Market: By Application

  • Epigenomics
    • Chromatin Immunoprecipitation (ChIP-Seq)
    • Bisulfite Sequencing
    • Methylated DNA Immunoprecipitation (MeDIP)
    • Chromatin Accessibility Assays
    • High-Resolution Melt (HRM)
    • Microarray Analysis
  • Functional
    • Real-Time PCR
    • Transfection
    • RNA Interference
    • SNP Analysis
    • Mutational Analysis
    • Microarray Analysis
  • Biomarker Discovery
    • Real-Time PCR
    • Mass Spectrometry
    • Microarray Analysis
    • Bioinformatics
    • Statistical Analysis
    • DNA Sequencing
  • Pathway Analysis
    • Microarray Analysis
    • Bead-Based Analysis
    • Real-Time PCR
    • Proteomics Tools
    • Others

Global Genomics Market: By End-User

  • Government and Academic Institutes
  • Clinical Research
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Clinics
  • Others

Global Genomics Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Genomics market, 2016-2025 (USD Billion)
    • 2.2. Global Genomics market: Snapshot
  •  
  • Chapter 3. Genomics Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. An increasing number of research projects in genomics
      • 3.2.2. Diminishing sequencing costs
    • 3.3. Market Restraints
      • 3.3.1. The dearth of skilled professionals
      • 3.3.2. High cost of equipment required in genomics
    • 3.4. Opportunities
      • 3.4.1. Increasing trend of collaborations between research institutes and companies
      • 3.4.2. Rising popularity of personalized medicine
    • 3.5. Porter's Five Forces analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Deliverables
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by End-User
      • 3.6.4. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global GenomicsMarket - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Genomics market: company market share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Genomics Market - Deliverables Analysis
    • 5.1. Global Genomics market: Deliverables overview
      • 5.1.1. Global Genomics market revenue share, by Deliverables, 2018 and 2025
    • 5.2. Services
      • 5.2.1. Global Genomics market for Services, 2016-2025 (USD Billion)
    • 5.3. Products
      • 5.3.1. Global Genomics market for Products, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Genomics Market - Application Analysis
    • 6.1. Global Genomics market: Application overview
      • 6.1.1. Global Genomics market revenue share, by Application, 2018 and 2025
    • 6.2. Epigenomics
      • 6.2.1. Global Genomics market for Epigenomics, 2016-2025 (USD Billion)
    • 6.3. Functional
      • 6.3.1. Global Genomics market for Functional, 2016-2025 (USD Billion)
    • 6.4. Biomarker Discovery
      • 6.4.1. Global Genomics market for Biomarker Discovery, 2016-2025 (USD Billion)
    • 6.5. Pathway Analysis
      • 6.5.1. Global Genomics market for Pathway Analysis, 2016-2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global Genomics market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Genomics Market - End-User Analysis
    • 7.1. Global Genomics Market: End-User overview
      • 7.1.1. Global Genomics market revenue share, by End-User, 2018 and 2025
    • 7.2. Government and Academic Institutes
      • 7.2.1. Global Genomics market for Government and Academic Institutes, 2016-2025 (USD Billion)
    • 7.3. Clinical Research
      • 7.3.1. Global Genomics market for Clinical Research, 2016-2025 (USD Billion)
    • 7.4. Biotechnology and Pharmaceutical Companies
      • 7.4.1. Global Genomics market for Biotechnology and Pharmaceutical Companies, 2016-2025 (USD Billion)
    • 7.5. Hospitals and Clinics
      • 7.5.1. Global Genomics market for Hospitals and Clinics, 2016-2025 (USD Billion)
    • 7.6. Others
      • 7.6.1. Global Genomics market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global GenomicsMarket - Regional Analysis
    • 8.1. Global Genomics market: Regional overview
      • 8.1.1. Global Genomics market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
      • 8.2.2. North America Genomics market revenue, by Application, 2016-2025 (USD Billion)
      • 8.2.3. North America Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.2.4.2. The U.S. Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.2.4.3. The U.S. Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.2.5.2. Rest of North America Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.2.5.3. Rest of North America Genomics market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
      • 8.3.2. Europe Genomics market revenue, by Application, 2016-2025 (USD Billion)
      • 8.3.3. Europe Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.4. Germany
        • 8.3.4.1. Germany Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.3.4.2. Germany Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.4.3. Germany Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.3.5.2. UK Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.5.3. UK Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.3.6.2. France Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.6.3. France Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.3.7.2. Rest of Europe Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.7.3. Rest of Europe Genomics market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific Genomics market revenue, by Application, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.4.4.2. China Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.4.3. ChinaGenomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.4.5.2. Japan Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.5.3. Japan Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.4.6.2. India Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.6.3. India Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Genomics market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
      • 8.5.2. Latin America Genomics market revenue, by Application, 2016-2025 (USD Billion)
      • 8.5.3. Latin America Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.5.4.2. Brazil Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.5.4.3. Brazil Genomics market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Genomics market revenue, by Application, 2016-2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Genomics market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Genomics market revenue, by Deliverables, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa Genomics market revenue, by Application, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa Genomics market revenue, by End-User, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Illumina Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Drug Deliverables portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Thermo Fisher Scientific, Inc.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Drug Deliverables portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. QIAGEN N.V.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Drug Deliverables portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Eurofins Scientific
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Drug Deliverables portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Agilent Technologies, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Drug Deliverables portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. GE Healthcare
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Drug Deliverables portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. BGI
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Drug Deliverables portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Bio-Rad Laboratories, Inc.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Drug Deliverables portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. DNASTAR
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Drug Deliverables portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments
    • 9.10. Oxford Nanopore Technologies
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Drug Deliverables portfolio
      • 9.10.4. Business strategy
      • 9.10.5. Recent developments
    • 9.11. F. Hoffmann-La Roche Ltd.
      • 9.11.1. Overview
      • 9.11.2. Financials
      • 9.11.3. Drug Deliverables portfolio
      • 9.11.4. Business strategy
      • 9.11.5. Recent developments

List of Figures

1. Market research process
2. Market research methodology
3. Global Genomics market revenue, 2016–2025 (USD Billion)
4. Porter’s Five Forces analysis
5. Genomics Market attractiveness analysis, by Deliverables
6. Genomics Market attractiveness analysis, by Application
7. Genomics Market attractiveness analysis, by End-User
8. Genomics: Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global Genomics market revenue share by Deliverables, 2018 and 2025
11. Global Genomics market for Services, 2016–2025 (USD Billion)
12. Global Genomics market for Products, 2016–2025 (USD Billion)
13. Global Genomics market revenue share by Application, 2018 and 2025
14. Global Genomics market for Epigenomics, 2016–2025 (USD Billion)
15. Global Genomics market for Genomics, 2016–2025 (USD Billion)
16. Global Genomics market for Biomarker Discovery, 2016–2025 (USD Billion)
17. Global Genomics market for Pathway Analysis, 2016–2025 (USD Billion)
18. Global Genomics market for Others, 2016–2025 (USD Billion)
19. Global Genomics Market by End-User, 2016–2025 (USD Billion)
20. Global Genomics market for Government and Academic Institutes, 2016–2025 (USD Billion)
21. Global Genomics market for Clinical Research, 2016–2025 (USD Billion)
22. Global Genomics market for Biotechnology and Pharmaceutical Companies, 2016–2025 (USD Billion)
23. Global Genomics market for Hospitals and Clinics, 2016–2025 (USD Billion)
24. Global Genomics market for Others, 2016–2025 (USD Billion)
25. North America Genomics market, 2016–2025 (USD Billion)
26. Europe Genomics market, 2016–2025 (USD Billion)
27. Asia Pacific Genomics market, 2016–2025 (USD Billion)
28. Latin America Genomics market, 2016–2025 (USD Billion)
29. The Middle East and Africa Genomics market, 2016–2025 (USD Billion)


List of Tables

1. Genomics Market: Market Snapshot                                                                                                                        
2. Drivers of global Genomics market: Impact analysis
3. Restraints of global Genomics market: Impact analysis
4. Opportunities of global Genomics market: Impact analysis
5. North America Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
6. North America Genomics market revenue, by Application, 2016–2025 (USD Billion)
7. North America Genomics market revenue, by End-User, 2016–2025 (USD Billion)
8. The U.S. Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
9. The U.S. Genomics market revenue, by Application, 2016–2025 (USD Billion)
10. The U.S. Genomics market revenue, by End-User, 2016–2025 (USD Billion)
11. Rest of North America Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
12. Rest of North America Genomics market revenue, by Application, 2016–2025 (USD Billion)
13. Rest of North America Genomics market revenue, by End-User, 2016–2025 (USD Billion)
14. Europe Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
15.  Europe Genomics market revenue, by Application, 2016–2025 (USD Billion)
16.  Europe Genomics market revenue, by End-User, 2016–2025 (USD Billion)
17. Germany Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
18. Germany Genomics market revenue, by Application, 2016–2025 (USD Billion)
19. Germany Genomics market revenue, by End-User, 2016–2025 (USD Billion)
20. UK Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
21. UK Genomics market revenue, by Application, 2016–2025 (USD Billion)
22. UK Genomics market revenue, by End-User, 2016–2025 (USD Billion)
23. France Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
24. France Genomics market revenue, by Application, 2016–2025 (USD Billion)
25. France Genomics market revenue, by End-User, 2016–2025 (USD Billion)
26. Rest of Europe Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
27. Rest of Europe Genomics market revenue, by Application, 2016–2025 (USD Billion)
28. Rest of Europe Genomics market revenue, by End-User, 2016–2025 (USD Billion)
29. Asia Pacific Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
30. Asia Pacific Genomics market revenue, by Application, 2016–2025 (USD Billion)
31. Asia Pacific Genomics market revenue, by End-User, 2016–2025 (USD Billion)
32. China Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
33. China Genomics market revenue, by Application, 2016–2025 (USD Billion)
34. China Genomics market revenue, by End-User, 2016–2025 (USD Billion)
35. Japan Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
36. Japan Genomics market revenue, by Application, 2016–2025 (USD Billion)
37. Japan Genomics market revenue, by End-User, 2016–2025 (USD Billion)
38. India Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
39. India Genomics market revenue, by Application, 2016–2025 (USD Billion)
40. India Genomics market revenue, by End-User, 2016–2025 (USD Billion)
41. Rest of Asia Pacific Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
42. Rest of Asia Pacific Genomics market revenue, by Application, 2016–2025 (USD Billion)
43. Rest of Asia Pacific Genomics market revenue, by End-User, 2016–2025 (USD Billion)
44. Latin America Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
45. Latin America Genomics market revenue, by Application, 2016–2025 (USD Billion)
46. Latin America Genomics market revenue, by End-User, 2016–2025 (USD Billion)
47. Brazil Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
48. Brazil Genomics market revenue, by Application, 2016–2025 (USD Billion)
49. Brazil Genomics market revenue, by End-User, 2016–2025 (USD Billion)
50. Rest of Latin America Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
51. Rest of Latin America Genomics market revenue, by Application, 2016–2025 (USD Billion)
52. Rest of Latin America Genomics market revenue, by End-User, 2016–2025 (USD Billion)
53. The Middle East and Africa Genomics market revenue, by Deliverables, 2016–2025 (USD Billion)
54. The Middle East and Africa Genomics market revenue, by Application, 2016–2025 (USD Billion)
55. The Middle East and Africa Genomics market revenue, by End-User, 2016–2025 (USD Billion)

Methodology

Free Analysis

Genomics is a stream of biology that focuses on the function, structure, evolution, editing, and mapping of genomes. Genomics also includes the investigation of genomes through using bioinformatics and high throughput sequencing of DNA for assembling and analyzing the structure and function of complete genomes. Developments in genomics have prompted a revolution in exploration-based investigation and systems biology to simplify the understanding of even the most intricate biological structures like the human brain.

The increasing number of research projects in genomics, diminishing sequencing cost, expanding applications of genomics, escalating demand for nucleic acid sequencing, rising research and development activity in drug discovery and molecular biology, market growth initiatives taken by public and private organizations, entry of start-ups in genomics, and rising genomics support in advance of tailored medicines are major factors driving the global genomics market. The popularization of collaborations between research institutes and companies and the rising preference for personalized medicine are likely to offer new growth opportunities to the players of the global genomics market. However, the dearth of skilled professionals, high equipment costs required in genomics, and the lack of awareness may restrict the global genomics market in the years ahead.

Global Genomics Market

The global genomics market has been split into deliverables, application, and end user. Based on deliverables, the genomics market includes services and products. The products segment is expected to dominate the market over the estimated time period, majorly due to the recurrent use of instruments and reagents for genomics research and the rising number of research programs undertaken by government and private organizations. The application segment includes epigenomics, functional, biomarker discovery, pathway analysis, and others. Functional division dominated the application segment in 2018, due to the generation of a huge volume of sequencing data. The end-user segment includes government and academic institutes, clinical research, biotechnology and pharmaceutical companies, hospitals and clinics, and others. Biotechnology and pharmaceutical companies are expected to dominate the market, due to the increasing number of genetic research training.

North America will lead in the future and accounted for over 38% of the global genomics market in 2018. Continuous funding for life sciences research from private organizations and government institutions, growing implementation of tailored medicines, increasing investments made by academic institutions in genomics research, the presence of state-of-the-art healthcare facilities, and early adoption of latest technologies are boosting the North American market. Europe will be the second largest market in the future, owing to the presence of skilled researchers, high R&D investments made by leading companies, increasing geriatric population, the rising prevalence of chronic disorders, and positive reimbursement scenario. The Asia Pacific market will propagate at speedily over the forecast time period, due to the rising incidences of chronic diseases, growing interest in genomics, increasing research and development on genomics applications, and escalating use of genomics in disease diagnosis.

Some key players of the global genomics market are Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Eurofins Scientific, Agilent Technologies, Inc., GE Healthcare, BGI, Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, and F. Hoffmann-La Roche Ltd.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social